Bolin Cheng
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 7
- Glycosylation and Glycoproteins Research 2
- Advanced biosensing and bioanalysis techniques 2
-
- Nanoparticle-Based Drug Delivery 6
- Co-authors
- Fuqiang Hu (9 shared papers)Hong Yuan (8 shared papers)Tingting Meng (6 shared papers)Jian You (4 shared papers)Yongzhong Du (2 shared papers)Yingwen Hu (4 shared papers)Xiangting Zhuang (1 shared paper)Zhiping Zhang (1 shared paper)
- Journals
- Oncotarget (2 papers)ACS Applied Materials & Interfaces (2 papers)Molecular Pharmaceutics (1 paper)International Journal of Nanomedicine (1 paper)Nanomedicine Nanotechnology Biology and Medicine (1 paper)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Bolin Cheng
17 papers receiving 708 citations
Peers
Comparison fields: 5 of 82
- Biomaterials 329
- Pharmaceutical Science 97
- Molecular Medicine 25
- Biomedical Engineering 225
- Molecular Biology 294
Countries citing papers authored by Bolin Cheng
This map shows the geographic impact of Bolin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolin Cheng more than expected).
Fields of papers citing papers by Bolin Cheng
This network shows the impact of papers produced by Bolin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolin Cheng. The network helps show where Bolin Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Bolin Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 185 | |
| 2 | 2014 | 132 | |
| 3 | 2016 | 119 | |
| 4 | 2016 | 80 | |
| 5 | 2016 | 45 | |
| 6 | 2023 | 23 | |
| 7 | 2021 | 21 | |
| 8 | 2015 | 17 | |
| 9 | 2021 | 17 | |
| 10 | 2016 | 15 | |
| 11 | [Radiosensitizing effects of Lycium barbarum polysaccharide for Lewis lung cancer]. | 1991 | 13 |
| 12 | 2017 | 12 | |
| 13 | 2015 | 11 | |
| 14 | 2016 | 9 | |
| 15 | Effect of curcumin on diabetic rat model of cerebral ischemia. | 2015 | 7 |
| 16 | 2016 | 2 | |
| 17 | 2016 | 2 |
About Bolin Cheng
Bolin Cheng is a scholar working on Molecular Biology, Biomaterials, Oncology, Biomedical Engineering and Infectious Diseases, having authored 17 papers that have together received 710 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (3 papers), Glycosylation and Glycoproteins Research (2 papers), Chemokine receptors and signaling (2 papers), COVID-19 Clinical Research Studies (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Biomaterials (329 citations), Pharmaceutical Science (97 citations), Molecular Medicine (25 citations), Biomedical Engineering (225 citations) and Molecular Biology (294 citations). Bolin Cheng has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Fuqiang Hu, Hong Yuan, Tingting Meng, Jian You, Yongzhong Du, Yingwen Hu, Xiangting Zhuang, Zhiping Zhang, Dan Li and Na Liu. Their work appears in journals such as Oncotarget, ACS Applied Materials & Interfaces, Molecular Pharmaceutics, International Journal of Nanomedicine and Nanomedicine Nanotechnology Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.